
Hematol Am Soc Hematol Educ Prog 159–165. Īdamson JW (2008) The anemia of inflammation/malignancy: mechanisms and management. There is no change in MPV levels before and after treatment when normal platelet count IDA is treated, but there is a decrease in platelet count and an increase in PDW.īasu S, Kumar N, Srivastava R, Kumar A (2015) Effect of severe maternal iron deficiency anemia on neonatal platelet indices. When IDA was treated, there was a decrease in plateletcrit, platelet distribution width (PDW), and platelet count from platelet parameters. In addition, MPV levels of PRG (8.84 ± 1.08) and CRG (8.96 ± 1.11) with IDA therapy were similar at the end of the study ( p > 0.05). Complete response to treatment group (CRG) was the patients whose haemoglobin was above 12 g/dL, MCV is above 80 fL, and ferritin is above 15 ng/ml ( n = 64). The partial response to treatment group (PRG) was accepted as haemoglobin level between 10 and 12 g/dL, mean corpuscular volume (MCV) below 80 fL, and ferritin below 15 ng/ml ( n = 60). Patients with IDA were divided into two groups as partial and complete response. IDA patients ( n = 124) and the control group (CG) ( n = 124) who fulfilled the inclusion criteria were compared for MPV and platelet parameters. Study further aimed to determine changing of platelet parameters treatment response of IDA. To determine the relationship between mean platelet volume (MPV) and treatment response of iron deficiency anaemia (IDA) with normal platelet count.
